Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study
Authors
Keywords
Malignant pleural effusion, Osteopontin, Pleurodesis, Survival, Urokinase-type plasminogen activator, Vascular endothelial growth factor
Journal
BMC CANCER
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-13
DOI
10.1186/s12885-016-2529-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study
- (2015) Marta Korsic et al. WIENER KLINISCHE WOCHENSCHRIFT
- Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer
- (2014) He Zhang et al. BMC CANCER
- Estrogen adversely affects the prognosis of patients with lung adenocarcinoma
- (2014) Li-Han Hsu et al. CANCER SCIENCE
- A Urokinase Receptor-Derived Peptide Inhibiting VEGF-Dependent Directional Migration and Vascular Sprouting
- (2013) K. Bifulco et al. MOLECULAR CANCER THERAPEUTICS
- VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution
- (2012) Revu Ann Alexander et al. CARDIOVASCULAR RESEARCH
- VEGF and sVEGFR-1 in malignant pleural effusions: Association with survival and pleurodesis outcomes
- (2012) C.E. Hooper et al. LUNG CANCER
- Mechanisms of Pleurodesis
- (2012) Francisco Rodriguez-Panadero et al. RESPIRATION
- Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
- (2011) T. Hirata et al. EUROPEAN RESPIRATORY JOURNAL
- Reduction of Elevated Plasma Osteopontin Levels With Resection of Non–Small-Cell Lung Cancer
- (2010) Justin D. Blasberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum Osteopontin Levels are Highly Prognostic for Survival in Advanced Non-small Cell Lung Cancer: Results from JMTO LC 0004
- (2010) Shun-Ichi Isa et al. Journal of Thoracic Oncology
- Tunneled Pleural Catheters for Treatment of Recurrent Malignant Pleural Effusion Following Failed Pleurodesis
- (2010) Raymond H. Thornton et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis
- (2009) R. Cosin et al. HUMAN REPRODUCTION
- Osteopontin Promotes Vascular Endothelial Growth Factor Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Paracrine Mechanisms
- (2008) G. Chakraborty et al. CANCER RESEARCH
- Fibrinolysis: The Key to New Pathogenetic Mechanisms
- (2008) Esther Zorio et al. CURRENT MEDICINAL CHEMISTRY
- Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003
- (2008) Philip C. Mack et al. JOURNAL OF CLINICAL ONCOLOGY
- Osteopontin is involved in the formation of malignant pleural effusion in lung cancer
- (2008) Ri Cui et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now